Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marci D Jones

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The Journal of Biological Chemistry|September 1, 2004
1,25-dihydroxyvitamin D3 down-regulation of PHEX gene expression is mediated by apparent repression of a 110 kDa transfactor that binds to a polyadenine element in the promoterEric R Hines, Olga I Kolek, Marci D Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2010
A proteasome inhibitor, bortezomib, inhibits breast cancer growth and reduces osteolysis by downregulating metastatic genesMarci D Jones, Julie C Liu, Thomas K Barthel, et al.
The Journal of Biological Chemistry|June 17, 2011
Runx2 protein expression utilizes the Runx2 P1 promoter to establish osteoprogenitor cell number for normal bone formationJulie C Liu, Christopher J Lengner, Tripti Gaur, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The Journal of Biological Chemistry|September 1, 2004
1,25-dihydroxyvitamin D3 down-regulation of PHEX gene expression is mediated by apparent repression of a 110 kDa transfactor that binds to a polyadenine element in the promoterEric R Hines, Olga I Kolek, Marci D Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2010
A proteasome inhibitor, bortezomib, inhibits breast cancer growth and reduces osteolysis by downregulating metastatic genesMarci D Jones, Julie C Liu, Thomas K Barthel, et al.
The Journal of Biological Chemistry|June 17, 2011
Runx2 protein expression utilizes the Runx2 P1 promoter to establish osteoprogenitor cell number for normal bone formationJulie C Liu, Christopher J Lengner, Tripti Gaur, et al.
Pageof 2